BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nanni O, Volpi A, Frassineti GL, De Paola F, Granato AM, Dubini A, Zoli W, Scarpi E, Turci D, Oliverio G, Gambi A, Amadori D. Role of biological markers in the clinical outcome of colon cancer. Br J Cancer 2002;87:868-75. [PMID: 12373601 DOI: 10.1038/sj.bjc.6600569] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. Br J Cancer. 2009;101:1749-1757. [PMID: 19844231 DOI: 10.1038/sj.bjc.6605368] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
2 Fridman WH, Miller I, Sautès-Fridman C, Byrne AT. Therapeutic Targeting of the Colorectal Tumor Stroma. Gastroenterology 2020;158:303-21. [PMID: 31622621 DOI: 10.1053/j.gastro.2019.09.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
3 Heijmen L, ter Voert EE, Oyen WJ, Punt CJ, van Spronsen DJ, Heerschap A, de Geus-Oei LF, van Laarhoven HW. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer. PLoS One. 2015;10:e0120823. [PMID: 25831053 DOI: 10.1371/journal.pone.0120823] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
4 Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol. 2006;210:351-357. [PMID: 16981251 DOI: 10.1002/path.2056] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 5.3] [Reference Citation Analysis]
5 Tsai HL, Yang IP, Lin CH, Chai CY, Huang YH, Chen CF, Hou MF, Kuo CH, Juo SH, Wang JY. Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. Int J Colorectal Dis. 2013;28:415-424. [PMID: 22961433 DOI: 10.1007/s00384-012-1570-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
6 Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006;94:1823-32. [PMID: 16773076 DOI: 10.1038/sj.bjc.6603176] [Cited by in Crossref: 238] [Cited by in F6Publishing: 226] [Article Influence: 15.9] [Reference Citation Analysis]
7 Peng Y, Wang L, Gu J. Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer. World J Surg. 2013;37:208-213. [PMID: 23052808 DOI: 10.1007/s00268-012-1814-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
8 Horton JK, Tepper JE. Staging of colorectal cancer: past, present, and future. Clin Colorectal Cancer 2005;4:302-12. [PMID: 15663833 DOI: 10.3816/ccc.2005.n.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A, Kombouras C. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res. 2008;147:99-107. [PMID: 17655863 DOI: 10.1016/j.jss.2007.05.041] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
10 Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009;27:5944-5951. [PMID: 19858404 DOI: 10.1200/jco.2008.19.6147] [Cited by in Crossref: 582] [Cited by in F6Publishing: 355] [Article Influence: 48.5] [Reference Citation Analysis]
11 Duff SE, Jeziorska M, Kumar S, Haboubi N, Sherlock D, O'Dwyer ST, Jayson GC. Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer. Colorectal Dis. 2007;9:793-800. [PMID: 17931169 DOI: 10.1111/j.1463-1318.2006.01199.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
12 Leme MB, Waitzberg AF, Artigiani Neto R, Linhares MM, Matos D. [Assessment of angiogenesis expression and its relationship with prognosis of colorectal cancer by conventional and computer-assisted histopathological image analysis]. Acta Cir Bras 2006;21:392-7. [PMID: 17160251 DOI: 10.1590/s0102-86502006000600007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
13 Ferroni P, Spila A, Martini F, D'Alessandro R, Mariotti S, Del Monte G, Graziano P, Buonomo O, Guadagni F, Roselli M. Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer. Oncology. 2005;69:145-153. [PMID: 16146041 DOI: 10.1159/000087838] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
14 Park HR, Min K, Kim HS, Jung WW, Park YK. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Pathol Res Pract 2008;204:575-82. [PMID: 18440723 DOI: 10.1016/j.prp.2008.01.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
15 Funaioli C, Pinto C, Mutri V, Di Fabio F, Ceccarelli C, Angelo Martoni A. Does Biomolecular Characterization of Stage II/III Colorectal Cancer Have Any Prognostic Value? Clinical Colorectal Cancer 2006;6:38-45. [DOI: 10.3816/ccc.2006.n.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Theodoropoulos GE, Lazaris AC, Theodoropoulos VE, Papatheodosiou K, Gazouli M, Bramis J, Patsouris E, Panoussopoulos D. Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis. 2006;21:248-257. [PMID: 16052307 DOI: 10.1007/s00384-005-0788-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
17 Formentini A, Henne-bruns D, Kornmann M. Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review. Langenbecks Arch Surg 2004;389:405-13. [DOI: 10.1007/s00423-004-0510-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
18 Westra JL, Hollema H, Schaapveld M, Platteel I, Oien KA, Keith WN, Mauritz R, Peters GJ, Buys CH, Hofstra RM. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients. Ann Oncol. 2005;16:1646-1653. [PMID: 16012177 DOI: 10.1093/annonc/mdi316] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
19 Pagès F, Galon J, Fridman WH. The essential role of the in situ immune reaction in human colorectal cancer. J Leukoc Biol 2008;84:981-7. [PMID: 18559950 DOI: 10.1189/jlb.1107773] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
20 Popat S, Matakidou A, Houlston RS. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2004;22:529-536. [PMID: 14752076 DOI: 10.1200/jco.2004.05.064] [Cited by in Crossref: 338] [Cited by in F6Publishing: 116] [Article Influence: 19.9] [Reference Citation Analysis]
21 Libra M, Navolanic PM, Talamini R, Cecchin E, Sartor F, Tumolo S, Masier S, Travali S, Boiocchi M, Toffoli G. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy. BMC Cancer 2004;4:11. [PMID: 15040806 DOI: 10.1186/1471-2407-4-11] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
22 Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA. The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer 2004;4:38-45. [PMID: 15207019 DOI: 10.3816/ccc.2004.n.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
23 Duff SE, Jeziorska M, Rosa DD, Kumar S, Haboubi N, Sherlock D, O’dwyer ST, Jayson GC. Vascular endothelial growth factors and receptors in colorectal cancer: Implications for anti-angiogenic therapy. European Journal of Cancer 2006;42:112-7. [DOI: 10.1016/j.ejca.2005.09.018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
24 Wang S, Liu Y, Shi Y, Guan J, Liu M, Wang W. Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer. J Int Med Res 2021;49:3000605211015023. [PMID: 33990147 DOI: 10.1177/03000605211015023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Gosens MJ, Moerland E, Lemmens VP, Rutten HT, Tan-Go I, van den Brule AJ. Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer. Int J Cancer. 2008;123:1941-1949. [PMID: 18661526 DOI: 10.1002/ijc.23740] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
26 Jakob C, Liersch T, Meyer W, Baretton GB, Häusler P, Schwabe W, Becker H, Aust DE. Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy. Am J Surg Pathol 2005;29:1304-9. [PMID: 16160472 DOI: 10.1097/01.pas.0000170346.55304.88] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
27 Moreira LR, Almeida Schenka A, Latuff Filho P, Nascimento H, Passos Lima CS, Silva Trevisan MA, Vassallo J. Correlation Between Thymidylate Synthase Protein Expression and Gene Polymorphism with Clinicopathological Parameters in Colorectal Carcinoma. Int J Surg Pathol 2009;17:181-6. [DOI: 10.1177/1066896908330480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Popat S, Chen Z, Zhao D, Pan H, Hearle N, Chandler I, Shao Y, Aherne W, Houlston R. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer. Ann Oncol. 2006;17:1810-1817. [PMID: 16971666 DOI: 10.1093/annonc/mdl301] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
29 Hanna DL, Loupakis F, Yang D, Cremolini C, Schirripa M, Li M, Matsusaka S, Berger MD, Miyamoto Y, Zhang W, Ning Y, Antoniotti C, Salvatore L, Moran M, Zeger G, Astrow SH, Falcone A, Lenz HJ. Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. Clin Colorectal Cancer 2018;17:e471-88. [PMID: 29636300 DOI: 10.1016/j.clcc.2018.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Allen WL, Johnston PG. Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer. Pharmacogenomics 2005;6:603-14. [DOI: 10.2217/14622416.6.6.603] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
31 Lin M, Lin HZ, Ma SP, Ji P, Xie D, Yu JX. Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer. Med Oncol 2011;28:151-8. [PMID: 20107934 DOI: 10.1007/s12032-010-9427-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
32 Chen Y, Yi C, Liu L, Li B, Wang Y, Wang X. Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data. Int J Biol Markers. 2012;27:e203-e211. [PMID: 23015402 DOI: 10.5301/jbm.2012.9584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
33 Jubb AM, Hurwitz HI, Bai W, Holmgren EB, Tobin P, Guerrero AS, Kabbinavar F, Holden SN, Novotny WF, Frantz GD. Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol. 2006;24:217-227. [PMID: 16365183 DOI: 10.1200/jco.2005.01.5388] [Cited by in Crossref: 306] [Cited by in F6Publishing: 125] [Article Influence: 19.1] [Reference Citation Analysis]
34 Bertout J, Thomas-tikhonenko A. Infection & Neoplastic Growth 101. In: Dalgleish AG, Haefner B, editors. The Link Between Inflammation and Cancer. Boston: Springer US; 2006. pp. 167-97. [DOI: 10.1007/0-387-26283-0_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Park CM, Lee WY, Chun HK, Cho YB, Yun HR, Heo JS, Yun SH, Kim HC. Relationship of polymorphism of the tandem repeat sequence in the thymidylate synthase gene and the survival of stage III colorectal cancer patients receiving adjuvant 5-flurouracil-based chemotherapy. J Surg Oncol. 2010;101:22-27. [PMID: 19798689 DOI: 10.1002/jso.21412] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]